|
|
stem cell development
|
GO:0048864 |
219 |
0.536
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.500
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.456
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.455
|
Human |
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.418
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.406
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.405
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.371
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.371
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.347
|
Human |
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.298
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.287
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.285
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.282
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.280
|
Human |
|
|
forebrain development
|
GO:0030900 |
302 |
0.275
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.275
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.266
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.264
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.262
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.243
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.241
|
Human |
|
|
blastocyst development
|
GO:0001824 |
80 |
0.237
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.234
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.233
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.220
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.215
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.213
|
Human |
|
|
histone modification
|
GO:0016570 |
159 |
0.213
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.211
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.211
|
Human |
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.205
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.195
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.192
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.185
|
Human |
|
|
innate immune response
|
GO:0045087 |
157 |
0.179
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.179
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.179
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.179
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.179
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.177
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.176
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.175
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.174
|
Human |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.173
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.166
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.164
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.158
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.158
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.153
|
Human |
|
|
neural tube formation
|
GO:0001841 |
108 |
0.150
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.149
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.146
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.145
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.139
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.137
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.134
|
Human |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.134
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.131
|
|
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.127
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.126
|
Human |
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.124
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.123
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.121
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.121
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.121
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.120
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.119
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.117
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.117
|
Human |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.117
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.116
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.114
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.113
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.113
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.113
|
Human |
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.112
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.112
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.111
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.110
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.110
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.108
|
Human |
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.108
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.105
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.104
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.103
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.101
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.101
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.101
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.100
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.100
|
Human |
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.100
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.100
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.099
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.097
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.097
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.097
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.096
|
Human |
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.095
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.094
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.093
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.092
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.091
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.090
|
Human |
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.090
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.089
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.089
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.089
|
Human |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.089
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.088
|
Human |
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.088
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.086
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.086
|
Human |
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.086
|
Human |
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.086
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.086
|
Human |
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.085
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.084
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.083
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.082
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.082
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.081
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.081
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.081
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.080
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.080
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.079
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.079
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.079
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.078
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.078
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.076
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.076
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.076
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.076
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.075
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.075
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.074
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.074
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.073
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.072
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.071
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.071
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.070
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.070
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.069
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.069
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.069
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.069
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.068
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.068
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.067
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.067
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.067
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.066
|
Human |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.066
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.066
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.065
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.065
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.065
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.064
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.064
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.063
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.063
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.063
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.062
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.062
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.062
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.061
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.061
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.061
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.061
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.061
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.061
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.061
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.060
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.060
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.060
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.059
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.059
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.059
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.058
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.058
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.058
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.058
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.057
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.057
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.057
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.057
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.056
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.056
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.056
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.056
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.055
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.055
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.054
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.054
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.054
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.054
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.053
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.052
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.052
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.052
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.052
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.052
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.052
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.051
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.051
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.051
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.051
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.051
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.051
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.051
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.050
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.050
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.050
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.050
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.050
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.049
|
Human |
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.049
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.049
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.049
|
Human |
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.048
|
Human |
|
|
nose development
|
GO:0043584 |
12 |
0.048
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.048
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.048
|
Human |
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.048
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.048
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.047
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
Human |
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.047
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.047
|
Human |
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.047
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.047
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.046
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.045
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.045
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.045
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.045
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.045
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.044
|
Human |
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.043
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.043
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.043
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.043
|
Human |
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.043
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.042
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.042
|
|
|
|
viral genome replication
|
GO:0019079 |
17 |
0.042
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.042
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.041
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.041
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.041
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.041
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.041
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.040
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.040
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.040
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.040
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.040
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.040
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.039
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.039
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.039
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.039
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.039
|
|
|
|
regulation of myd88 independent toll like receptor signaling pathway
|
GO:0034127 |
1 |
0.039
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.039
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.038
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.038
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.038
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.038
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.038
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.038
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.038
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.037
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.037
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.037
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.037
|
Human |
|
|
cell maturation
|
GO:0048469 |
127 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.037
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.037
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.037
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.037
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.037
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.036
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.036
|
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.036
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.036
|
|
|
|
regulation of cd8 positive alpha beta t cell proliferation
|
GO:2000564 |
1 |
0.036
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.036
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.036
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.036
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.035
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.035
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.035
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.035
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.035
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.035
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.035
|
|
|
|
response to type i interferon
|
GO:0034340 |
12 |
0.035
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.034
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.034
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.034
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.033
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.033
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.033
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.033
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.033
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.033
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.033
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.032
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.032
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.032
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.032
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.032
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.032
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.032
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
Human |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.031
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.030
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.030
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.030
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.030
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.030
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.030
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.030
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.030
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to dna damage
|
GO:1902229 |
14 |
0.030
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.030
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.029
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.029
|
Human |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.029
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.029
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.029
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.029
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.029
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.028
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.028
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.028
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.028
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.028
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.028
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.028
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.028
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.028
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.028
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.028
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.028
|
|
|
|
regulation of myd88 dependent toll like receptor signaling pathway
|
GO:0034124 |
2 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.028
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.028
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.027
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.027
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
8 |
0.027
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.027
|
Human |
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.027
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.027
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.027
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.027
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.027
|
|
|
|
regulation of necroptotic process
|
GO:0060544 |
10 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.027
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.026
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.026
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.026
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.026
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.026
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.026
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.025
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.025
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.025
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.025
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.025
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.025
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.025
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.025
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.024
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.024
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
27 |
0.024
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.024
|
|
|
|
response to antibiotic
|
GO:0046677 |
11 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.024
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.024
|
|
|
|
negative regulation of histone deacetylation
|
GO:0031064 |
2 |
0.023
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.023
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.023
|
Human |
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.023
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.023
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.023
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.023
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.023
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.022
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.022
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.022
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.022
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.022
|
Human |
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.022
|
Human |
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.022
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.022
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.022
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.022
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.022
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.022
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.022
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.022
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.022
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.022
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.021
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.021
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.021
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.021
|
Human |
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
negative regulation of interferon beta production
|
GO:0032688 |
3 |
0.021
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.021
|
|
|
|
face development
|
GO:0060324 |
38 |
0.021
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.020
|
Human |
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.020
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.020
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.020
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.020
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.020
|
Human |
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.020
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.020
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.020
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.020
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.020
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.020
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.020
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.020
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.019
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.019
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.019
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.019
|
|
